Editorial: NK Cells in Human Diseases: Friends or Foes?

por Vieillard, Vincent, Foley, Bree, López-Vergès, Sandra L.
Publicado en Front Immunol (2017)

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)

por Barnes, Samantha, Schilizzi, Ophelia, Audsley, Katherine M., Newnes, Hannah V., Foley, Bree
Publicado en Int J Mol Sci (2020)

The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)

por Foley, Bree, Felices, Martin, Cichocki, Frank, Cooley, Sarah, Verneris, Michael R., Miller, Jeffrey S.
Publicado 2014

NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions

por Foley, Bree, Cooley, Sarah, Verneris, Michael R., Curtsinger, Julie, Luo, Xianghua, Waller, Edmund K., Weisdorf, Daniel J., Miller, Jeffrey S.
Publicado 2011

Human CMV-induced Memory-like NKG2C(+) NK cells are Transplantable and Expand in vivo in Response to Recipient CMV Antigen()

por Foley, Bree, Cooley, Sarah, Verneris, Michael R., Curtsinger, Julie, Luo, Xianghua, Waller, Edmund K., Anasetti, Claudio, Weisdorf, Daniel, Miller, Jeffrey S.
Publicado 2012

NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)

por Romee, Rizwan, Foley, Bree, Lenvik, Todd, Wang, Yue, Zhang, Bin, Ankarlo, Dave, Luo, Xianghua, Cooley, Sarah, Verneris, Mike, Walcheck, Bruce, Miller, Jeffrey
Publicado 2013

Impaired T cell proliferation by ex vivo BET-inhibition impedes adoptive immunotherapy in a murine melanoma model

por Chee, Jonathan, Wilson, Chelsea, Buzzai, Anthony, Wylie, Ben, Forbes, Catherine A, Booth, Mitchell, Principe, Nicola, Foley, Bree, Cruickshank, Mark N, Waithman, Jason
Publicado en Epigenetics (2019)

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C(+) natural killer cells with potent function

por Foley, Bree, Cooley, Sarah, Verneris, Michael R., Pitt, Michelle, Curtsinger, Julie, Luo, Xianghua, Lopez-Vergès, Sandra, Lanier, Lewis L., Weisdorf, Daniel, Miller, Jeffrey S.
Publicado 2012

Functional NK cell repertoires are maintained through IL-2Rα and FasL

por Felices, Martin, Lenvik, Todd R., Ankarlo, Dave E.M., Foley, Bree, Curtsinger, Julie, Luo, Xianghua, Blazar, Bruce R., Anderson, Stephen K., Miller, Jeffrey S.
Publicado 2014

Acquired resistance during adoptive cell therapy by transcriptional silencing of immunogenic antigens

por Wylie, Ben, Chee, Jonathan, Forbes, Catherine A, Booth, Mitchell, Stone, Shane R, Buzzai, Anthony, Abad, Ana, Foley, Bree, Cruickshank, Mark N, Waithman, Jason
Publicado en Oncoimmunology (2019)

Cross-presentation of cutaneous melanoma antigen by migratory XCR1(+)CD103(−) and XCR1(+)CD103(+) dendritic cells

por Wylie, Ben, Seppanen, Elke, Xiao, Kun, Zemek, Rachael, Zanker, Damien, Prato, Sandro, Foley, Bree, Hart, Prue H, Kroczek, Richard A, Chen, Weisan, Waithman, Jason
Publicado en Oncoimmunology (2015)

CD8(+)XCR1(neg) Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic Receptors

por Wylie, Ben, Read, James, Buzzai, Anthony C., Wagner, Teagan, Troy, Niamh, Syn, Genevieve, Stone, Shane R., Foley, Bree, Bosco, Anthony, Cruickshank, Mark N., Waithman, Jason
Publicado en Front Immunol (2019)

Targeting Natural Killer cells to Acute Myeloid Leukemia in vitro with a CD16x33 bispecific killer cell engager (BiKE) and ADAM17 inhibition

por Wiernik, Andres, Foley, Bree, Zhang, Bin, Verneris, Michael R., Warlick, Erica, Gleason, Michelle K., Ross, Julie A., Luo, Xianghua, Weisdorf, Daniel J., Walcheck, Bruce, Vallera, Daniel A, Miller, Jeffrey S.
Publicado 2013

Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes

por Buzzai, Anthony C., Wagner, Teagan, Audsley, Katherine M., Newnes, Hannah V., Barrett, Lucy W., Barnes, Samantha, Wylie, Ben C., Stone, Shane, McDonnell, Alison, Fear, Vanessa S., Foley, Bree, Waithman, Jason
Publicado en Front Immunol (2020)

Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B‐ and T‐cell acute lymphoblastic leukaemia

por Foley, Bree, Ta, Clara, Barnes, Samantha, de Jong, Emma, Nguyen, Michelle, Cheung, Laurence C, Buzzai, Anthony, Wagner, Teagan, Wylie, Ben, Fernandez, Sonia, Cruickshank, Mark, Endersby, Raelene, Kees, Ursula, Waithman, Jason
Publicado en Clin Transl Immunology (2020)

New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment

por Cheung, Laurence C., Tickner, Jennifer, Hughes, Anastasia M., Skut, Patrycja, Howlett, Meegan, Foley, Bree, Oommen, Joyce, Wells, Julia E., He, Bo, Singh, Sajla, Chua, Grace-Alyssa, Ford, Jette, Mullighan, Charles G., Kotecha, Rishi S., Kees, Ursula R.
Publicado en Leukemia (2018)

Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function

por Schlums, Heinrich, Cichocki, Frank, Tesi, Bianca, Theorell, Jakob, Beziat, Vivien, Holmes, Tim D., Han, Hongya, Chiang, Samuel C.C., Foley, Bree, Mattsson, Kristin, Larsson, Stella, Schaffer, Marie, Malmberg, Karl-Johan, Ljunggren, Hans-Gustaf, Miller, Jeffrey S., Bryceson, Yenan T.
Publicado en Immunity (2015)